Veru Valuation Multiples

Veru Overview

About Veru

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

Founded

1971

HQ

Employees

20

Website

verupharma.com

Sectors

BiopharmaceuticalsBioTechFemTechSexTech

Financials (LTM)

Revenue: —

Net Income: ($25M)

EV

$8M

Valuation Multiples

Multiples.vc

Start free trial

Veru Financials

Veru reported last 12-month revenue of —.

In the same LTM period, Veru generated — in gross profit and had net loss of ($25M).

Veru P&L

In the most recent fiscal year, Veru reported revenue of — and EBITDA of ($35M).

Veru expects next 12-month revenue of XXX and NTM EBITDA of XXX

Veru Stock Performance

Veru has current market cap of $41M, and enterprise value of $8M.

Veru's stock price is $2.53.

Veru Valuation Multiples

Veru trades at (0.2x) EV/EBITDA.

Veru Financial Valuation Multiples

As of April 7, 2026, Veru has market cap of $41M and EV of $8M.

Equity research analysts estimate Veru's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Veru has a P/E ratio of (1.7x).

Veru Margins & Growth Rates

Veru's revenue in the last fiscal year declined by (100%).

Veru's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $1.8M for the same period.

Veru Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

Veru M&A Activity

Veru acquired XXX companies to date.

Last acquisition by Veru was on XXXXXXXX, XXXXX. Veru acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Veru Investment Activity

Veru invested in XXX companies to date.

Veru made its latest investment on XXXXXXXX, XXXXX. Veru invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).